Renuka Raman

Employment

• Weill Cornell Medicine Postdoctoral Associate
  2018 - Present
• Icahn School of Medicine at Mount Sinai Postdoctoral Fellow
  2017 - 2018

Education

• Tata Institute of Fundamental Research Ph.D.
  2009 - 2017

Projects & Funding

Projects & funding information is unavailable.

Publications (17)

• Palmitoyl-protein thioesterase-1 in health and disease
  Trends in Pharmacological Sciences 2026 DOI: 10.1016/j.tips.2026.01.002
  +Save
• Inhibition of equilibrative nucleoside transporters 1 and 2 by proteolysis-targeting chimeras (PROTACs)
  The Journal of Pharmacology and Experimental Therapeutics 2025 DOI: 10.1016/j.jpet.2025.103635
  +Save
• The regulation of CD73 in non-small cell lung cancer
  European Journal of Cancer 2022 DOI: 10.1016/j.ejca.2022.04.025
  +Save
• Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET–rearranged thyroid cancer
  Journal of Experimental Medicine 2022 DOI: 10.1084/jem.20210390
  +Save
• Exploiting mesothelin in thymic carcinoma as a drug delivery target for anetumab ravtansine
  British Journal of Cancer 2022 DOI: 10.1038/S41416-021-01658-6
  +Save
• Histone 3 Methyltransferases Alter Melanoma Initiation and Progression Through Discrete Mechanisms
  Frontiers in Cell and Developmental Biology 2022 DOI: 10.3389/FCELL.2022.814216
  +Save
• PPP6C, a serine-threonine phosphatase, regulates melanocyte differentiation and contributes to melanoma tumorigenesis through modulation of MITF activity
  Scientific Reports 2022 DOI: 10.1038/S41598-022-08936-0
  +Save
• COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies
  Biomolecules 2021 DOI: 10.3390/biom11070993
  +Save
• Uncovering the mechanism of adaptive resistance to RET inhibitors in RET rearranged thyroid cancer
  Cancer Research 2021
  +Save
• FANCI functions as a repair/apoptosis switch in response to DNA crosslinks.
  Developmental cell 2021 DOI: 10.1016/j.devcel.2021.06.010
  +Save